个人简历
工作经历 2001.7-至今 中山大学肿瘤防治中心鼻咽科 教授/主任医师/科副主任 教育经历 2004.9-2007.6 中山大学肿瘤防治中心鼻咽科 肿瘤学 博士 1998.9-2001.6 中山大学第一附属医院耳鼻咽喉科 耳鼻咽喉科 硕士 1993.9-1998.6 南华大学医学院 临床医学学士 出国/出境学习经历 2011.2-2012.3 美国马里兰大学医学院 博士后 2009.6-2009.9 香港大学玛丽医院头颈外科 Fellowship 2009.4-2009.5 荷兰癌症中心列文虎克医院头颈肿瘤外科 访问学者 行政经历 2015.2-至今中山大学肿瘤防治中心鼻咽科 科副主任 2013.9-2014.8 教育部科技司2011办公室（北京） 借调工作
研究领域
主要从事鼻咽癌的多学科综合治疗，擅长于鼻咽癌放射治疗，转移鼻咽癌综合治疗，复发鼻咽癌微创外科治疗等等。
近期论文
1.Qian Zhu, Xiong Zou, Rui You, Rou Jiang, Men-Xia Zhang, You-Ping Liu, Chao-Nan Qian, Hai-Qiang Mai, Ming-Huang Hong, Lin Guo*, Ming-Yuan Chen*. Establishment of an innovative staging system for extramedullary plasmacytoma. BMC Cancer. 2016 Oct 8;16(1):777. 2.Meng-Xia Zhang, Yi-Jun Hua, Hai-Yun Wang, Ling Zhou, Hai-Qiang Mai, Xiang Guo, Chong Zhao, Wen-Lin Huang, Ming-Huang Hong*, Ming-Yuan Chen*. Long Term Prognostic Implication and therapeutic target role of Hexokinase II in Patients with Nasopharyngeal Carcinoma. Oncotarget. 2016 19;7(16):21287-97. 3.Jiang R, You R, Pei XQ, Zou X, Zhang MX, Wang TM, Sun R, Luo DH, Huang PY, Chen QY, Hua YJ, Tang LQ, Guo L, Mo HY, Qian CN, Mai HQ, Hong MH, Cai HM*, Ming-Yuan Chen*. Development of a ten-signature classifier using a support vector machine integrated approach to subdivide the M1 stage into M1a and M1b stages of nasopharyngeal carcinoma with synchronous metastases to better predict patients' survival. Oncotarget. 2016, 19;7(3):3645-57. 4.Deng CC, Xu M, Li J, Luo XL, Zhu YJ, Jiang R, Zhang MX, Lei JJ, Lian YF, Zou X, You R, Chen LZ, Feng QS, Bei JX, Ming-Yuan Chen*, Zeng YX*. Unconjugated Bilirubin Is a Novel Prognostic Biomarker for Nasopharyngeal Carcinoma and Inhibits Its Metastasis via Antioxidation Activity. Cancer Prev Res (Phila). 2016, 9(2):180-8. 5.Sang Y#, Chen MY#, Luo D#, Zhang RH, Wang L, Li M, Luo R, Qian CN, Shao JY, Zeng YX, Kang T. TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma. Oncotarget. 2015 Oct 6;6(30):29240-53. 6.Zhang MX, Li J, Shen GP, Zou X, Xu JJ, Jiang R, You R, Hua YJ, Sun Y, Ma J, Hong MH, Chen MY*. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up. Eur J Cancer. 2015 Nov;51(17):2587-95. 7.Jiang R, Cai XY, Yang ZH, Yan Y, Zou X, Guo L, Sun R, Luo DH, Chen QY, Huang PY, Xiang YQ, Lu X, Wang L, Xia WX, Mai HQ, Chen MY*. Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma. Chin J Cancer. 2015 Jun 10;34(6):237-46. 8.Rui You, Xiong Zou, Rou Jiang, Lin-Quan Tang, Wei-Dong Zhang, Li Li, Meng-Xia Zhang, Guo-Ping Shen, Ling Guo, Xiang Guo, Chao-Nan Qian, Hai-Qiang Mai, Jun Ma, Ming-Huang Hong, Ming-Yuan Chen*. New Surgical Staging System for Patients with Recurrent Nasopharyngeal Carcinoma based on the AJCC/UICC rTNM Classification System. European Journal of Cancer. 2015 Sep;51(13):1771-9. 9.Rui You, Xiong Zou, Yi-Jun Hua, Fei Han, Li Li, Chong Zhao, Ming-Huang Hong, Ming-Yuan Chen*. Salvage Endoscopic Nasopharyngectomy is Superior to Intensity-Modulated Radiation Therapy for Local Recurrence of Selected T1-T3 Nasopharyngeal Carcinoma --- a Case-Matched Comparison. Radiotherapy & Oncology. 2015 Jun;115(3):399-406. 10.Rou Jiang, Xiong Zou, Wen Hu, Yu-Ying Fan, Yue Yan, Meng-Xia Zhang, Rui You, Rui Sun, Dong-Hua Luo, Qiu-Yan Chen, Pei-Yu Huang, Yi-Jun Hua, Ling Guo, Ming-Yuan Chen*. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients. Tumor Biology. 2015 Sep;36(10):7775-87. 11.Rou Jiang, Zhong-Han Yang, Xiu-Yu Cai, Yue Yan, Xiong Zou, Ling Guo, Rui Sun, Dong-Hua Luo, Qiu-Yan Chen, Pei-Yu Huang, Yan-Qun Xiang, Xing Lu, Lin Wang, Wei-Xiong Xia, Hai-Qiang Mai, Ming-Yuan Chen*. The elevated peripheral blood lymphocyte/monocyte ratio predicts favorable prognosis in metastatic nasopharyngeal carcinoma. Chinese Journal of Cancer. 2015 Jun 10;34(1):23. 12.Jing Li, Xiong Zou, Yun-Long Wu, Jing-Cui Guo, Jing-Ping Yun, Miao Xu, Qi-Sheng Feng, Li-Zhen Chen, Jin-Xin Bei, Yi-Xin Zeng, Ming-Yuan Chen*. A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort. PLoS One. 2014 Dec 23;9(12):e116261. 13.Xiong Zou, Fei Han, Wen-Juan Ma, Man-Quan Deng, Rou Jiang, Lin Guo, Qing Liu, Hai-Qiang Mai, Ming-Huang Hong, Ming-Yuan Chen*. Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma. Head Neck. 2015 Aug;37(8):1108-15. 14.Rou Jiang, Zhong-Han Yang, Dong-Hua Luo, Lin Guo, Rui Sun, Qiu-Yan Chen, Pei-Yu Huang, Fang Qiu, Xiong Zou, Ka-Jia Cao, Hai-Qiang Mai, Xiang Guo, Chao-Nan Qian, Ming-Huang Hong, Ming-Yuan Chen*. Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma. Med Oncol. 2014 Aug;31(8):80. 15.Yi Sang, Li Wang, Jian-Jun Tang, Mei-Fang Zhang, Meng-Xia Zhang, Xia Liu, Ru-Hua Zhang, Tie-Bang Kang, Ming-Yuan Chen*. Oncogenic roles of carbonic anhydrase IX in human nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2014, 7(6):2942-9. 16.Xiang-Bo Wan, Rou Jiang, Fang-Yun Xie, Zhen-Yu Qi, Ai-Ju Li, Wei-Jun Ye, Yi-Jun Hua, Yu-Liang Zhu, Xiong Zou, Ling Guo, Hai-Qiang Mai, Xiang Guo, Ming-Huang Hong, Ming-Yuan Chen*. Endoscope-guided Interstitial Intensity -Modulated Brachytherapy and Intracavitary Brachytherapy as Boost Radiation for Primary Early T Stage Nasopharyngeal Carcinoma. PLoS One. 2014 Mar 3;9(3):e90048. 2014. 17.Ming-Yuan Chen; Yi-Jun Hua; Hai-Qiang Mai, et al. Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis (PRNN). Chin J Cancer. 2013, 32(10):533-8.
